Trial intelligence / Profile preview

12-Hour vs 24-Hour Magnesium Sulphate for Eclampsia in Sudan

NCT03112551Unknown

Sponsor
Gadarif University
Start
Dec 2018
Primary completion
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of magnesium sulfate in eclampsia (2 arms), sponsored by Gadarif University. Primary endpoint: Number of patients who will receive magnesium sulfate and develop drug toxicity. Status: unknown.

02

Drugs

magnesium sulfate
03

Conditions

eclampsia

Beyond the preview

Go deeper on NCT03112551.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03112551.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call